P. Dongiovanni

DGAT1 and DGAT2 Inhibitors for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Benefits for Their Single or Combined Application

M. Meroni, E. Paolini, Miriam Longo, 2024, International journal of molecular sciences.